Advent controlled-BSV has charted an exceptional turnaround over the last five years, seeing a 3x jump in its valuation. Its specialised products in women’s health and a robust research pipeline makes it a cynosure of all eyes. As Mankind announces acquisition of BSV in a USD1.6 billion deal, ET Prime explains the company’s journey and its outlook.